Novartis | Capital Social E Reservas



Equity Capital And Reserves Alterar Data
AbbVie USD 1.46B 1.86B 2025-03
Alcon AG USD 22.13B 111M 2025-06
Almirall EUR 1.46B 37.19M 2025-06
Amgen USD 7.43B 1.22B 2025-06
AstraZeneca USD 44.72B 3.68B 2025-06
Autolus Therapeutics Ltd 346.46M 24.64M 2025-06
Bayer EUR 30.5B 2.08B 2025-06
Biogen USD 17.63B 655.3M 2025-06
Bristol-Myers Squibb USD 17.49B 100M 2025-06
Eli Lilly USD 18.27B 2.43B 2025-06
Fresenius EUR 18.94B 465M 2025-06
Fresenius Medical Care EUR 14.33B 1.18B 2025-06
Galapagos EUR 2.64B 104.07M 2025-06
Genmab DKK 5.3B 6M 2025-06
Gilead Sciences USD 19.67B 596M 2025-06
GlaxoSmithKline GBP 14.35B 197M 2025-06
GRIFOLS EUR 7.6B 1.96B 2025-06
Hikma Pharmaceutical USD 2.32B 35M 2024-12
J&J USD 78.11B 6.62B 2025-03
Lonza CHF 9.33B 23M 2024-12
Merck EUR 28.26B 1.64B 2025-06
Merck USD 49.06B 725M 2025-06
Novartis USD 42.05B 3.6B 2025-06
Novartis USD 42.05B 1.99B 2025-06
Novo Nordisk 168.07B 29.53B 2025-06
Orion EUR 919.6M 147.2M 2025-06
Pfizer USD 88.7B 1.64B 2025-06
Philips EUR 10.38B 1.32B 2025-06
Recordati EUR 1.87B 107.18M 2025-06
Regeneron Pharmaceuticals USD 29.94B 551.3M 2025-06
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 70.28B 3.8B 2025-06
UCB EUR 10.03B 1.08B 2024-12


Novartis Capital Social E Reservas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Sep 2025.